Valeant Pharmaceuticals International
- Pharmaceutical Preparations
- Quebec, Quebec, Canada
Compensation history
Top executives at Valeant Pharmaceuticals International received an average of $10M per person in annual compensation from 2007 to 2021.
Average pay of disclosed executives at Valeant Pharmaceuticals International
By year
- 2021
JP$23MJoseph C. PapaChief Executive OfficerTA$10MThomas J. AppioPresident Co, Head Bausch + Lomb/InternationalPH$7MPaul S. HerendeenFormer Executive Vice President and Chief Financial OfficerCA$5MChristina M. AckermannExecutive Vice President, General Counsel and Head of Commercial OperationsSE$4MSam A. EldessoukyExecutive Vice President and Chief Financial OfficerRS$4MRobert A. SpurrPresident, U.S. Pharma Business- 2020
JP$14MJoseph C. PapaChief Executive OfficerPH$6MPaul S. HerendeenFormer Executive Vice President and Chief Financial OfficerTA$4MThomas J. AppioPresident Co, Head Bausch + Lomb/InternationalCA$4MChristina M. AckermannExecutive Vice President, General Counsel and Head of Commercial OperationsSE$1MSam A. EldessoukyExecutive Vice President and Chief Financial Officer
Executives
We found 28 executives who work or worked at Valeant Pharmaceuticals International.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Robert Spurr
Valeant Pharmaceuticals International
President, U.S. Pharma Business
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
Joseph Gordon
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
William Humphries
Valeant Pharmaceuticals International
Group Chairman
News
About Valeant Pharmaceuticals International
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address2150 St. Elzear Blvd. West, Laval, Quebec, Quebec, Canada H7L 4A8
- Phone514-744-6792
- Fiscal year endDecember 31
- Former names
- Valeant Pharmaceuticals International, Inc.Until July 2, 2018
- BIOVAIL CorpUntil September 26, 2010
- BIOVAIL CORP INTERNATIONALUntil April 6, 2010
- BIOVAIL CORPORATION INTERNATIONALUntil January 4, 2001
Source: SEC filings on May 2, 2022, March 18, 2019, March 21, 2018, April 29, 2016, April 9, 2015, April 30, 2012, April 14, 2011, and April 21, 2010.